TY  - JOUR
T1  - Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers
AU  - Erdogan, Hatice
AU  - Pehlivanoglu, Filiz
AU  - Sengöz, Gönül
AU  - Velaei, Feride
PY  - 2022
DA  - December
DO  - 10.5799/jmid.1218640
JF  - Journal of Microbiology and Infectious Diseases
JO  - J Microbil Infect Dis
PB  - Aydın ECE
WT  - DergiPark
SN  - 2146-3158
SP  - 154
EP  - 159
VL  - 12
IS  - 04
LA  - en
AB  - Objectives: This study aims to evaluate the effectiveness of the inactivated SARS-COV-2 vaccine (Sinovac-CoronaVac), first administered to healthcare professionals in Turkey on January 14, 2021. Methods: Healthcare professionals without a history of COVID-19, PCR test positivity, or chronic disease were included in the study. The antibody levels for S1 RBD antigen were measured with the Siemens SARS-CoV-2 IgG (sCOVG) kit one month and six months after the two-dose CoronaVac vaccine.Results: A total of 108 health professionals, 35 women and 73 men, were included in this study. The mean age of the participants was 37.5 ± 10.7 years. A total of 103 (95.3%) individuals had positive antibody values, and five (4.6%) had negative values after the second vaccination. After the second vaccine dose, 11 (10.1%) participants were diagnosed with COVID-19. There was a significant decrease in antibody values in the sixth month compared to the first month (p
KW  - COVID-19
KW  - healthcare professionals
KW  - vaccination
UR  - https://doi.org/10.5799/jmid.1218640
L1  - https://dergipark.org.tr/en/download/article-file/2830068
ER  -